Multi-centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency

PURPOSE: To investigate whether a new liquid formulation of recombinant human growth hormone (r-hGH) induces the production of binding antibodies (BAbs) in adults with congenital or adult-onset growth hormone deficiency (GHD). METHODS: Men or women aged 19–65 years with adult growth hormone deficien...

Descripción completa

Detalles Bibliográficos
Autores principales: Johannsson, G., Nespithal, K., Plöckinger, U., Alam, V., McLean, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061248/
https://www.ncbi.nlm.nih.gov/pubmed/29488103
http://dx.doi.org/10.1007/s40618-017-0818-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061248/
https://www.ncbi.nlm.nih.gov/pubmed/29488103
http://dx.doi.org/10.1007/s40618-017-0818-4

Ejemplares similares